课题基金 / 基金详情

Vitamin E-bisphosphonate conjugates: A new therapeutic approach targeting pathological bone loss associated with osteoporosis

Vitamin E-bisphosphonate conjugates: A new therapeutic approach targeting pathological bone loss associated with osteoporosis
维生素 E-二磷酸盐结合物:一种针对与骨质疏松症相关的病理性骨丢失的新治疗方法
批准号:
nhmrc : 1050694
负责人:
Prof Andreas Evdokiou
金额:
$31.47万
依托单位:
依托单位国家:
澳大利亚
项目类别:
Project Grants
财政年份:
2013
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2013-01-01 至 2015-12-31

项目摘要

项目成果

Prof Andreas Evdokiou的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Approximately 2 million Australians have osteoporosis, a disease which increases the risk of fracture and whose monetary and social costs are large and growing. The objective of this proposal is to exploit the osteotropic properties of novel compounds of
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Novel therapeutic approaches for the treatment of skeletal malignancies
  • 批准号:
    nhmrc : 627015
  • 项目类别:
    Career Development Fellowships
  • 资助金额:
    $29.09万
  • 财政年份:
    2010
  • 负责人:
    Prof Andreas Evdokiou
  • 依托单位:
Antitumour efficacy of TRAIL: an immunotherapeutic approach for the treatment of skeletal malignancies
  • 批准号:
    nhmrc : 565357
  • 项目类别:
    NHMRC Project Grants
  • 资助金额:
    $30.61万
  • 财政年份:
    2009
  • 负责人:
    Prof Andreas Evdokiou
  • 依托单位:
Targeting the" vicious cycle" of cancer-induced bone disease with TRAIL and bisphosphonates
  • 批准号:
    nhmrc : 453644
  • 项目类别:
    NHMRC Project Grants
  • 资助金额:
    $29.59万
  • 财政年份:
    2007
  • 负责人:
    Prof Andreas Evdokiou
  • 依托单位:
Use of TRAIL therapy to selectively kill bone tissue cancer cells whilst sparing normal cells
  • 批准号:
    nhmrc : 349359
  • 项目类别:
    Career Development Fellowships
  • 资助金额:
    $30.24万
  • 财政年份:
    2005
  • 负责人:
    Prof Andreas Evdokiou
  • 依托单位:
海外基金